IDH Inhibitors and Immunotherapy for Biliary Tract Cancer: A Marriage of Convenience?

Systemic treatments have traditionally reported limited efficacy for biliary tract cancer (BTC), and although targeted therapies and immune checkpoint inhibitors have been found to play an increasingly important role in treatment, several questions remain unanswered, including the identification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandi, Giovanni, Rizzo, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503989/
https://www.ncbi.nlm.nih.gov/pubmed/36142781
http://dx.doi.org/10.3390/ijms231810869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503989/
https://www.ncbi.nlm.nih.gov/pubmed/36142781
http://dx.doi.org/10.3390/ijms231810869

Ejemplares similares